With a doctorate in pharmacy, he has vast experience as a qualified person (QP), a pharmaceutical qualification required for drugs in Europe. He organizes the subcontractors needed to coordinate the pharmaceutical cases. He was a founder, manager and qualified person of the Montpellier-based CRID Pharma, which became Amatsi and then recently Eurofins, which he headed for 20 years. This company is a pharmaceutical services company specializing in pharmaceutical development (formulation, analytical development, approval of manufacturing processes, ICH stability studies, quality control and pharmaceutical writing) and in drug management for clinical trials. In 2011 he merged CRID Pharma with Avogadro to form Amatsi, a 175-person group located in France and the United States offering all services related to drug development. Since 2013 Jean-Pascal Conduzorgues has had his own consulting firm, Ibero, where he assists with pharmaceutical planning and initiatives by biotechnology companies he chooses to support as a shareholder and consultant, as is the case for OSE Immunotherapeutics.